Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 226.4 SEK -1.14% Market Closed
Market Cap: 30.7B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vitrolife AB
Cash & Cash Equivalents Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
SOBI
BIOA B

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Cash & Cash Equivalents
kr925m
CAGR 3-Years
-42%
CAGR 5-Years
9%
CAGR 10-Years
23%
Biogaia AB
STO:BIOG B
Cash & Cash Equivalents
kr1.5B
CAGR 3-Years
2%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cash & Cash Equivalents
kr153.2m
CAGR 3-Years
-12%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Cash & Cash Equivalents
kr717.4m
CAGR 3-Years
-17%
CAGR 5-Years
31%
CAGR 10-Years
26%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cash & Cash Equivalents
kr594m
CAGR 3-Years
41%
CAGR 5-Years
-11%
CAGR 10-Years
0%
BioArctic AB
STO:BIOA B
Cash & Cash Equivalents
kr611.6m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
N/A

See Also

What is Vitrolife AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
925m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Cash & Cash Equivalents amounts to 925m SEK.

What is Vitrolife AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
23%

Over the last year, the Cash & Cash Equivalents growth was 19%. The average annual Cash & Cash Equivalents growth rates for Vitrolife AB have been -42% over the past three years , 9% over the past five years , and 23% over the past ten years .

Back to Top